Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir vs Telaprevir in HCV Genotype 1b
NCT01492426Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Jan 2012; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01492426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01492426.